Glen Tinevez Email Address

Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks, and labs in more than 120 countries, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward.

COMMERCIAL SALES, MARKETING, and OPERATIONS EXECUTIVE Highly accomplished and driven enterprise business leader with a proven record achieving revenue, profit, and growth objectives within the diagnostic, medical device, and pharmaceutical sectors spanning both regional and global markets. Broad commercial, operational, and sales enablement competencies accompanied by a firm understanding of business process and profit and loss responsibility. Cultivates a growth mindset workplace culture anchored by clear goals and expectations that fosters innovation and resilience to drive sustainable value. Recognized as a hands-on leader with a bias for action and an aptitude to listen and nurture cross-functional collaboration to problem solve, improve process, and create shared value. SKILLS / COMPETENCIES Leadership, Customer Orientation, Business Development, PLCM, Launch, Digital Transformation CAREER HIGHLIGHTS Commercial Execution – Developed and implemented commercial go-to-market (GTM) strategies and built high-performance teams centered on the customer and a common purpose within the diagnostic and medical device sectors. Full year (FY) 2019 to Q2 2022 achieved CAGR% of 5.2% in Clinical Lab (CL) (ex-COVID) and CAGR% of 8.4% in Transfusion Medicine (TM) lines of business at Ortho Clinical Diagnostics. Sales Enablement – At Abbott, turned around an underperforming $72M business. Enabled organizational preparation, execution, and collaboration via operational strategies and processes resulting in business acceleration and growth through improved acquisition, integration, and value expansion activities. From 2011-13 generated +$5.9M revenue growth (+9%) and delivered 3x market growth. Strategy Development – Developed and launched "Because Every Test is a Life" brand promise and differentiated value proposition that defined Ortho’s “WHY”, aligned with customer priorities, embodied the mission of the company, unified the company voice, and enhanced customer understanding and engagement. Strategic Agility – Embraced Ortho’s mission by adapting, innovating, and collaborating to unlock growth with the execution of four product launches (COVID, PCT) in 2020 generating >$70M in revenue and became the fourth largest supplier of PCT testing in nine-months despite pandemic headwinds and global supply chain disruption.